ARTICLE | Clinical News
Coversin: Phase Ib started
February 8, 2016 8:00 AM UTC
Akari began a double-blind, vehicle-controlled, U.K. Phase Ib trial to evaluate ascending doses of once-daily subcutaneous Coversin in about 18 healthy volunteers. Subjects will receive an ablating do...